Drug intelligence / Profile preview

Biogrip Forte

Development stage
Unknown
Lead developer
Laboratorio Elea
Modality
Small Molecules
Administration
Oral
01

Overview

Biogrip Forte is an over-the-counter (OTC) combination medication developed and marketed by Laboratorios Elea Phoenix for the symptomatic treatment of influenza and the common cold. The product is a multi-ingredient small molecule therapy containing paracetamol (analgesic and antipyretic), phenylephrine (nasal decongestant), and carbepentane (antitussive), supplemented with vitamins B1 (thiamine) and C (ascorbic acid). It is specifically indicated for intense flu symptoms, including fever, pain, nasal congestion, and cough with phlegm. Laboratorios Elea Phoenix acquired the Bio-Grip brand from Sanofi in March 2020, and the product is currently part of Elea's OTC product line in Argentina.

Brand names
Biogrip ForteBio-Grip Forte
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)ADRA1A (α1A)HRH1 (Histamine H1 Receptor)SIGMAR1 (Sigma non-opioid intracellular receptor 1)mAChR (Muscarinic acetylcholine receptors)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on Biogrip Forte.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biogrip Forte.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call